VEGFC treatment to protect from diabetic nephropathy in type 1 diabetes: a translational approach

Foster, R. R. (Speaker)

Bristol Medical School (THS)

Activity: Other activity types › Other

Period	12 Feb 2020 → 11 Feb 2021
Held at	Bristol Medical School (THS)
Degree of Recognition	Local

Related content

Research Outputs
VEGFC reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy
Research output: Contribution to journal › Article (Academic Journal) › peer-review